Results

Total Results: 536 records

Showing results for "statin".
Users also searched for: statin

  1. cds.ahrq.gov/sites/default/files/cds/artifact/21/2024_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
    January 01, 2024 - Implementation Guide: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease (CVD) … drug (unless the patient is already on a statin). … Suggested action: Order a statin medication. 4. … Patient understood the recommendation but elects not to take a statin. iv. … muscle symptoms or an allergy to statin medication
  2. psnet.ahrq.gov/issue/errors-electronic-health-record-based-data-query-statin-prescriptions-patients-coronary
    March 12, 2025 - Study Errors in electronic health record–based data query of statin prescriptions … Errors in Electronic Health Record-Based Data Query of Statin Prescriptions in Patients With Coronary … The authors evaluated how their institution's EHR measured a common quality metric—statin prescription … Errors in Electronic Health Record-Based Data Query of Statin Prescriptions in Patients With Coronary
  3. www.uspreventiveservicestaskforce.org/home/getfilebytoken/k_QR3hvh2jVSPPLu6Q6m6r
    November 13, 2022 - STUDY SELECTION Randomized clinical trials on statins vs placebo or no statin and statin intensity in … Randomized clinical trials of statin therapy vs placebo or no statin, statin dosing strategies to target … statin dose. … based on trials of statins vs placebo or no statin stratified according to statin intensity showed no … therapy and higher- vs lower- intensity statin therapy; to more definitively determine whether statin
  4. www.uspreventiveservicestaskforce.org/home/getfilebytoken/yBxQssfCeRcD6BBeP2QjdQ
    Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Clinical Summary Figure. … Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Clinical Summary Population … Considerations for Implementation The likelihood that a patient will benefit from statin use depends … discuss with patients the potential risk of having a CVD event and the expected benefits and harms of statin … concludes that the evidence is insufficient to determine the balance of benefits and harms of initiating statin
  5. www.ahrq.gov/evidencenow/projects/heart-health/research-results/research/chart-abstraction-template-cholesterol.html
    March 01, 2021 - Cholesterol Oklahoma Cooperative Resource: Chart Abstraction Template—Cholesterol Control with Statin … template was used by an EvidenceNOW Cooperative to conduct chart abstractions for cholesterol control with statin
  6. cds.ahrq.gov/sites/default/files/cds/artifact/logic/2024-08/StatinTherapyForThePreventionAndTreatmentOfCVDeCQMDerived_Change_Log.txt
    January 01, 2024 - allergen" (2.16.840.1.113883.3.117.1.7.1.423) with "Statin Allergen" (2.16.840.1.113762.1.4.1110.42 … ) - Replace "Moderate intensity statin therapy" (2.16.840.1.113762.1.4.1047.98) value set with "Moderate … Intensity Statin Therapy" (2.16.840.1.113883.3.526.3.1575) - Replace "High intensity statin therapy" … Familial hypercholesterolemia reference code since it is now in the value set - Value Sets: Added Statin … - Population 3 Inclusions: Removed requirement for most recent LDL >= 70 mg/dL - Exclusions: Added Statin
  7. cds.ahrq.gov/sites/default/files/cds/artifact/logic/2024-08/USPSTFStatinUseForPrimaryPreventionOfCVDInAdultsPatientFacing_Change_Log.txt
    January 01, 2024 - Update CDSConnectCommonsForFHIRv102 to version 2.1.0 - Replace extensional value set "Low intensity statin … (currently expands to same codes) - Replace extensional value set "Moderate intensity statin therapy … (currently expands to same codes) - Replace extensional value set "High intensity statin therapy" … (currently expands to same codes) - Replace extensional value set "Moderate intensity statin therapy … (currently expands to same codes) - Replace extensional value set "High intensity statin therapy"
  8. www.ahrq.gov/evidencenow/projects/heart-health/research-results/research/cholesterol-flowchart.html
    March 01, 2021 - EvidenceNOW: Cholesterol Measure Flow Chart, National Evaluator Minnesota Cooperative Resource: Statin … Measure Flow Chart (PDF, 248.7 KB, 1 page) This document provides a process flow diagram for the Statin
  9. cds.ahrq.gov/sites/default/files/cds/artifact/logic/2024-08/USPSTFStatinUseForPrimaryPreventionOfCVDInAdults_Change_Log.txt
    January 01, 2024 - Update CDSConnectCommonsForFHIRv102 to version 2.1.0 - Replace extensional value set "Low intensity statin … (currently expands to same codes) - Replace extensional value set "Moderate intensity statin therapy … (currently expands to same codes) - Replace extensional value set "High intensity statin therapy" … (currently expands to same codes) - Replace extensional value set "Moderate intensity statin therapy … (currently expands to same codes) - Replace extensional value set "High intensity statin therapy"
  10. www.ahrq.gov/evidencenow/heart-health/cholesterol/uspstf.html
    September 01, 2018 - Clinical Recommendation: Statins in Primary Prevention of CVD Resource title: Statin Use for
  11. www.ahrq.gov/evidencenow/heart-health/cholesterol/primary-prevention.html
    September 01, 2018 - using assessment results and patient preferences to guide decisionmaking and improving adherence to statin
  12. www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/cholesterol-lipid-algorithm.pdf
    December 14, 2015 - comorbid conditions Repeat CVD risk evaluation 5-10%, every 2 y <5%, every 5 y Advise high-dose statinstatin Y Shared decision making results in statin initiation or continuation Y Y N Mediterranean … (stable symptoms of angina or equivalent) CVA or TIA Atherosclerotic PVD (Claudication or AAA) Statin … Dose, by 10-year CVD Risk 10-Year Risk Statin Dose ASCVD (second prevention) Moderate to high >10% … Moderate 5-10% (with shared decision making) Moderate <5% None Drug Doses Statin Moderate, mg High
  13. meps.ahrq.gov/data_files/publications/st459/stat459.shtml
    November 01, 2014 - STATISTICAL BRIEF #459: Changes in Statin Therapy among Adults (Age ≥ 18) by Selected Characteristics … XL   STATISTICAL BRIEF #459: Changes in Statin … Between 2000–2001 and 2010–2011, the average annual percentage of adults (age ≥ 18) reporting statin … Definitions Statin medications Each drug that was listed as purchased or otherwise obtained in the … medications, and each specific class of statin medication during the year.
  14. www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/measure-handout-mw.pdf
    June 02, 2025 - C No measure currently developed (For Randomizati on purposes only, run PQRS 163) Statin … Therapy for the Prevention and Treatment of Cardiovascular Disease The number of patients with a statin … medication (Statin RXNORM Value Set) current on the medication list or prescribed a statin medication
  15. cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
    October 01, 2017 - Implementation Guide: USPSTF Statin Use for Primary Prevention of CVD in Adults. … Basic Tests a Table 3: USPSTF Statin Exclusion Tests b Table 4: USPSTF Statin Inclusion Tests c Table … Suggested action: order for a statin medication. 6. … Aligns with ACC/AHA thoughts on contraindications for statin use. … is already receiving a statin.
  16. S131 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s131.pdf
    October 01, 2007 - On each statin user’s index date, we sampled a subject who had not used a statin as of that date (ie, … on a statin) and prevalent users (ie, those taking a statin for some time). … Cohort 1—Incident Statin Users and Nonusers Cohort 1a—Incident statin users and nonusers matched on … We restricted cohort 1 to incident statin users, defined as no statin use in the 12 months before the … Thirty-six percent of incident statin users and 22.5% of prevalent users stopped taking their statin.
  17. digital.ahrq.gov/ahrq-funded-projects/patient-centered-outcomes-research-clinical-decision-support-cds-connect/citation/uspstf
    January 01, 2023 - Implementation guide: USPSTF statin use for primary prevention of CVD in adults. … Implementation guide: USPSTF statin use for primary prevention of CVD in adults.
  18. cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM_Final.docx
    October 01, 2017 - Therapy eCQM Basic Tests a Table 3: Statin Therapy eCQM Exclusion Tests b Table 4: Statin Therapy eCQM … , a recommendation to consider ordering a statin drug is delivered. … Suggested action: order for a statin medication. 4. … Patient has understood the recommendation but elects not to take a statin. d. … 'consider' a statin).
  19. www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/cholesterol-pcor.pdf
    November 01, 2016 - Substantial PCOR evidence shows that taking a statin medication each day to manage blood cholesterol … People who have already had a heart attack or stroke have also been shown to benefit from statin use … contraindicated or not tolerated, all patients at high risk should receive a high- or moderate-intensity statin … Preventive Services Task Force (USPSTF) released recommendations supporting statin use in adults at … disease, those with high LDL cholesterol levels, and those with diabetes), who have been prescribed a statin
  20. www.uspreventiveservicestaskforce.org/home/getfilebytoken/mk-eb9VtB_jx885wnjuzk3
    January 01, 2024 - We included randomized trials of statin therapy vs pla- cebo or no statin and assessed all-cause mortality … Benefits of Statin Treatment Key Question 1a. … What are the harms of statin treatment? … 2 How do benefits and harms vary according to statin treatment potency? … What are the harms of statin treatment?

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive